NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/04/2026
Voltar para busca
Dado oficial do USPTO
HYLIQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
01/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 42
Data de depósito
13/07/2021
Data de registro
27/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2022
Última transação
01/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
US
Examinador
SIRIGNANO, EMMA MARIE
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Dermaliq Therapeutics Inc.
Dermaliq Therapeutics Inc.
NOVALIQ GmbH
Representantes
Barbara Guggenmos Guggenmos Rechtsanwaelte,
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
non-medicated skin care preparations; body cleaning and beauty care preparations in the nature of non-medicated skin treatments; sunscreen preparations; animal grooming preparations in the nature of non-medicated skin care and fur care; non-medicated gelsliquids and lotions for skin care; cosmetic preparations; cosmetic products in the nature of non-medicated preparations for skincare; cosmetic products in the form of aerosols for skin care; lipsticks; non-medicated mouthwash
Classe 5
Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of skin diseases; medicated preparations for skin treatment; disinfectants and antiseptics for use in dermatology; anti-bacterial preparations for use in dermatology; antimicrobials for dermatologic use; antiviral preparations for use in dermatology; antimycotics in the nature of antifungal preparations; antiparasitics; virostatics in the nature of antivirals; antibacterials for dermatologic use; fungicides for dermatologic use; anti-infective preparations for the skin
Classe 42
Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of dermatological and infectious diseases; testingauthentication and quality control of clinical and medical research in the field of dermatologic and infectious diseases; research and development in the field of cosmetics and skin care products; research and development in the field of dermatology
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/02/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/01/2023
FIMP
FINAL DISPOSITION PROCESSED
25/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/12/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
19/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2022
PUBO
PUBLISHED FOR OPPOSITION
12/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/06/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
25/05/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
26/04/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/04/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
26/04/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/04/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
22/04/2022
RFNT
REFUSAL PROCESSED BY IB
18/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/03/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/03/2022
RFRR
REFUSAL PROCESSED BY MPU
23/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/03/2022
CNRT
NON-FINAL ACTION WRITTEN
22/03/2022
DOCK
ASSIGNED TO EXAMINER
22/03/2022
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
02/03/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
05/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
09/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HYLIQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.